Krystal Biotech Inc (KRYS)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 182,883 | -42,637 | -77,807 | -41,883 | -15,096 |
| Revenue | US$ in thousands | 296,569 | 55,764 | 498 | — | — |
| Gross profit margin | 61.67% | -76.46% | -15,623.90% | — | — |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $182,883K ÷ $296,569K
= 61.67%
The gross profit margin of Krystal Biotech Inc has shown significant fluctuations over the years based on the provided data. In December 31, 2020, and December 31, 2021, the company reported negative gross profit margins, indicating a loss on its direct costs. This trend continued into December 31, 2022, with a substantial decrease in the gross profit margin at -15,623.90%. However, the company managed to improve its performance in December 31, 2023, with a less negative gross profit margin of -76.46%.
The most notable improvement was seen in December 31, 2024, with a significant increase in the gross profit margin to 61.67%. This suggests that the company was able to generate a higher percentage of revenue after accounting for direct production costs. This positive trend in the gross profit margin in 2024 indicates improved efficiency in production and potentially better pricing strategies.
Overall, the fluctuating trend in Krystal Biotech Inc's gross profit margin demonstrates the company's efforts to enhance its operational performance and profitability over the years, with a particularly notable improvement in 2024.
Peer comparison
Dec 31, 2024